Paclitaxel loaded fibrinogen coated CDTE/ZNTE core shell nanoparticles for targeted imaging and drug delivery to breast cancer cells

Journal of Biomedical Nanotechnology

Volumn 9, Issue 10, 2013, Pages 1657-1671

  Rejinold, N Sanoj ^a   Baby, Thejus ^a   Nair, Shantikumar V ^a   Jayakumar, R ^a  

^a AMRITA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Breast cancer drug delivery; Cellular imaging; Co Acervation; Fibrinogen; One Pot aqueous phase synthesis; QDs; 5 1 integrins

Indexed keywords

CADMIUM TELLURIDE; CELLS; CYTOLOGY; DISEASES; DRUG DELIVERY; GLYCOPROTEINS; MEDICAL IMAGING; PARTICLE SIZE;

AQUEOUS-PHASE SYNTHESIS; BREAST CANCER; CELLULAR IMAGING; FIBRINOGEN; INTEGRINS; QDS;

SEMICONDUCTOR QUANTUM DOTS;

CADNIUM TELLURIDE; CALCIUM CHLORIDE; FIBRINOGEN; PACLITAXEL; QUANTUM DOT; TELLURIUM; UNCLASSIFIED DRUG; VERY LATE ACTIVATION ANTIGEN 5; ZINC TELLURIDE; ANTINEOPLASTIC AGENT; CADMIUM DERIVATIVE; CADMIUM TELLURIDE; NANOCAPSULE; ZINC;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BREAST CANCER; CANCER CELL; CANCER LOCALIZATION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG RELEASE; FEMALE; FLUORESCENCE MICROSCOPY; HELA CELL LINE; HUMAN; HUMAN CELL; HYDROGEN BOND; IN VITRO STUDY; MCF 7 CELL LINE; MOUSE; MTT ASSAY; NONHUMAN; PARTICLE SIZE; SYNTHESIS; ZETA POTENTIAL; ANIMAL; BREAST NEOPLASMS; CHEMISTRY; DIFFUSION; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST NEOPLASMS; CADMIUM COMPOUNDS; CELL LINE, TUMOR; DIFFUSION; FEMALE; FIBRINOGEN; HUMANS; MICE; NANOCAPSULES; PACLITAXEL; TELLURIUM; ZINC;

EID: 84920803884     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2013.1657     Document Type: Article

References (51)

1. C. Yan, F. Tang, and L. Li, Synthesis of aqueous CdTe/CdS/ZnS core/shell/shell quantum dots by a chemical aerosol flow method. Nanoscale Res. Lett. 5, 194 (2010).
2. Y. Chen, T. Ji, and Z. Rosenzweig, Photo-assisted synthesis of highly fluorescent ZnSe(S) quantum dots in aqueous solution. Nano Lett. 3, 581 (2003).
3. D.V. Talapin, S. Haubold, and A. L. Rogach, Novel organo-metallic synthesis of highly luminescent CdTe nanocrystals. J. Phys. Chem. B 105, 2260 (2001).
4. J. I. Weng, X. T. Song, and L. Li, Exploring feasibility for application of luminescent CdTe quantum dots prepared in aqueous phase to live cell imaging. Chinese Chem. Lett. 17, 675 (2006).
5. W. C. Law, K. T. Yong, I. Roy, and P. N. Prasad, Aqueous-phase synthesis of highly luminescent CdTe/ZnTe Core/Shell quantum dots optimized for targeted bioimaging. Small 5, 1302 (2009).
6. S. Kumar and T. Nann, Shape control of II-VI semiconductor nanomaterials. Small 2, 316 (2006).
7. A. W. Maureen, J. A. Novak, and R. E. Jason, Quantum dots for live cell and in vivo imaging. Int. J. Mol. Sci. 10, 441 (2009).
8. M. Bruchez, M. Moronne, P. Gin, S. Weiss, and A. P. Alivisatos, Semiconductor nanocrystals as fluorescent biological labels. Science 281, 2013 (1998).
9. W. C. Chan and S. Nie, Quantum dot bioconjugates for ultrasensitive nonisotopic detection. Science 281, 2016 (1998).
10. C. B. Murray, D. J. Norris, and M. G. Bawendi, Synthesis and characterization of nearly monodisperse CdE (E = sulfur, selenium, tellurium) semiconductor nanocrystallites. J. Am. Chem. Soc. 115, 8706 (1993).
11. M. A. Hines and G. P. Sionnest, Synthesis and characterization of strongly luminescing ZnS capped CdSe nanocrystals. J. Phys. Chem. 100, 468 (1996).
12. M. Danek, K. F. Jensen, C. B. Murray, and M. G. Bawendi, Synthesis of luminescent thin-film CdSe/ZnSe quantum dot composites using CdSe quantum dots passivated with an over layer of ZnSe. Chem. Mater. 8, 173 (1996).
13. B. O. Dabbousi, V. J. Rodriguez, F. V. Mikulec, J. R. Heine, H. Mattoussi, R. Ober, K. F. Jensen, and M. G. Bawendi, (CdSe) ZnS core-shell quantum dots: Synthesis and characterization of a size series of highly luminescent nanocrystallites. J. Phys. Chem. B 101, 9463 (1997).
14. M. A. Hines and S. P. Guyot, Bright UV-blue luminescent colloidal ZnSe nanocrystals. J. Phys. Chem. B 102, 3655 (1998).
15. W. W. Yu and X. Peng, Formation of high-quality CdS and other II-VI semiconductor nanocrystals in noncoordinating solvents: Tunable reactivity of monomers. Angew. Chemie. 41, 2368 (2002).
16. D. J. Norris, N. Yao, F. T. Charnock, and T. A. Kennedy, Highquality manganese-doped ZnSe nanocrystals. Nano Lett. 1, 3 (2001).
17. M. Kuno and J. K. Lee, The band edge luminescence of surface modified CdSe nanocrystallites: Probing the luminescing state. J. Chem. Phys. 106, 9869 (1997).
18. S. Taniguchi, M. Green, S. B. Rizvi, and A. Seifalian, The onepot synthesis of core/shell/shell CdTe/CdSe/ZnSe quantum dots in aqueous media for in vivo deep tissue imaging. J. Mater. Chem. 21, 2877 (2011).
19. S. F. Wuister, I. Swart, and F. V. Driel, Highly luminescent watersoluble CdTe quantum dots. Nano Lett. 3, 503 (2003).
20. X. Gao and S. Nie, Quantum dot-encoded mesoporous beads with high brightness and uniformity. Anal. Chem. 76, 2406 (2004).
21. F. Chen and D. Gerion, Fluorescent CdSe/ZnS nanocrystal-peptide conjugates for long-term, nontoxic imaging and nuclear targeting in living cells. Nano Lett. 4, 1827 (2004).
22. J. K. Jaiswal, H. Mattoussi, J. M. Mauro, and S. M. Simon, Longterm multiple color imaging of live cells using quantum dot bio conjugates. Nat. Biotechnol. 21, 47 (2003).
23. B. Dubertret, P. Skourides, D. J. Norris, V. Noireaux, A. H. Brivanlou, and A. Libchaber, In vivo imaging of quantum dots encapsulated in phospholipid micelles. Science 298, 1759 (2002).
24. X. Wu, H. Liu, J. Liu, K. N. Haley, J. A. Treadway, J. P. Larson, N. Ge, F. Peale, and M. P. Bruchez, Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots. Nat. Biotechnol. 21, 41 (2003).
25. H. Mattoussi, J. M. Mauro, E. R. Goldman, T. M. Green, G. P. Anderson, V. C. Sundar, and M. G. Bawendi, Bioconjugation of highly luminescent colloidal CdSe-ZnS quantum dots with an engineered two-domain recombinant protein. Phys. Status Solid. 224, 277 (2001).
26. D. Fabienne, L. Nathalie, V, M. Benoît, B. Christine, J. Jacqueline, F. Olivier, and P. Véronique, Paclitaxel-loaded PEGylated PLGAbased nanoparticles: In vitro and in vivo evaluation. J. Control Release 133, 11 (2009).
27. A. K. Singla, A. Garg, and D. Aggarwal, Paclitaxel and its formulations. Int. J. Pharm. 235, 179 (2002).
28. C. M. Spencer and D. Faulds, Paclitaxel. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of cancer. Drugs 48, 794 (1994).
29. P. Schiff, J. Fant, and S. B. Horwitz, Promotion of microtubule assembly in vitro by Taxol. Nature 277, 665 (1979).
30. S. Haldar, J. Chintapalli, and C. M. Croce, Taxol induces bcl-2 phosphorylation and death of prostate cancer cells. Cancer Res. 56, 1253 (1996).
31. B. D. Tarr and S. H. Yalkowsky, A new parenteral vehicle for the administration of some poorly soluble anti-cancer drugs. J. Parenter. Sci. Technol. 41, 31 (1987).
32. R. B. Weiss, R. C. Donehower, and P. H. Wiernik, Hypersensitivity reactions from Taxol. J. Clin. Oncol. 8, 1263 (1990).
33. T. Yang and M. K. Choi, Preparation and evaluation of paclitaxelloaded PEGylated immunoliposome. J. Control Release 120, 169 (2007).
34. R. T. Liggins and H. M. Burt, Paclitaxel-loaded poly(L-lactic acid) microspheres 3: Blending low and high molecular weight polymers to control morphology and drug release. Int. J. Pharm. 282, 61 (2004).
35. Z. Zhang and S. S. Feng, The drug encapsulation efficiency, in vitro drug release, cellular uptake and cytotoxicity of paclitaxel-loaded poly (lactide)-tocopheryl polyethylene glycol succinate nanoparticles. Biomaterials 27, 4025 (2006).
36. K. M. Huh, H. S. Min, S. Cheon Lee, H. J. Lee, S. Kim, and K. Park, A new hydrotropic block copolymer micelle system for aqueous solubilization of paclitaxel. J. Control. Release. 126, 122 (2008).
37. J. M.Tsay, M. Pflughoefft, and L. A. Bentolila, Hybrid approach to the synthesis of highly luminescent CdTe/ZnS and CdHgTe/ZnS nanocrystals. J. Am. Chem. Soc. 126, 1926 (2008).
38. A. Agnihotri and C. A. Siedlecki, Time-dependent conformational changes in fibrinogen measured by atomic force microscopy. Langmuir 20, 8846 (2004).
39. C. E. Hall and H. S. Slayter, The fibrinogen molecule: Its size, shape, and mode of polymerization. J. Biophys. Biochem. Cytol. 5, 11 (1959).
40. F. R. Rickles, S. Patierno, and P. M. Fernandez, Tissue factor, thrombin, and cancer. Chest. 124, 58S (2003).
41. N. Sanoj Rejinold, M. Muthunarayanan, K.P. Chennazhi, S. V. Nair, and R. Jayakumar, Curcumin loaded fibrinogen nanoparticles for cancer drug delivery. J. Biomed. Nanotechnol. 48, 521 (2011).
42. 1via the carboxylterminal RGD site of the Aα-chain. J. Biochem. 128, 705 (2000).
43. J. K. Jackson, T. Hung, K. Letchford, and H. M. Burt, The characterization of paclitaxel-loaded microspheres manufactured from blends of poly(lactic-co-glycolic acid) (PLGA) and low molecular weight diblock copolymers. Int. J. Pharm. 342, 6 (2007).
44. V. Guillemard and H. Uri Saragovi, Taxane-antibody conjugates afford potent cytotoxicity, enhanced solubility, and tumor target selectivity, Cancer Res. 61, 694 (2001).
45. L. J. Hoon, G. Un-Sook, K. Jin-Hyun, K. Yongae, K. Seon-Ho, H. Oh, and M. Bumchan, Preparation and characterization of solvent induced dihydrated, anhydrous, and amorphous paclitaxel. Bull. Korean Chem. Soc. 22, 925 (2001).
46. N. Sanoj Rejinold, Amrita Nair, M. Sabitha, K. P. Chennazhi, H. Tamura, S. V. Nair, and R. Jayakumar, Synthesis, characterization and in vitro cytocompatibility studies of chitin nanogels for biomedical applications. Carbohydr. Polym. 87, 943 (2012).
47. K. Wen-Shuo, K. Yu-Cian, S. Hei-Tin, C. Fong-Yu, and Y. Chen-Sheng, Paclitaxel-loaded stabilizer-Free poly (D, L-lactide-co- glycolide) nanoparticles conjugated with quantum dots for reversion of anti-cancer drug resistance and cancer cellular imaging. J. Chin. Chem. Soci. 56, 923 (2009).
48. N. Sanoj Rejinold, M. Muthunarayanan, N. Deepa, K. P. Chennazhi, S. V. Nair, and R. Jayakumar, Development of novel fibrinogen nanoparticles by two step coacervation method. Int. J. Biol. Macromol. 37, 37 (2010).
49. N. Sanoj Rejinold, M. Muthunarayanan, N. Deepa, K. P. Chennazhi, S. V. Nair, and R. Jayakumar, 5-fluorouracil loaded fibrinogen nanoparticles for cancer drug delivery applications. Int. J. Biol. Macromol. 48, 97 (2011).
50. J. Xu, L. Ma, Y. Liu, F. Xu, J. Nie, and G. Ma, Design and characterization of antitumor drug paclitaxel-loaded chitosan nanoparticles by W/O emulsions. Int. J. Biol. Macromol. 50, 438 (2012).
51. A. Mayer, M. Vadon, B. Rinner, A. Novak, R. Wintersteiger, and E. Fröhlich, The role of nanoparticle size in hemocompatibility. Toxicology 258, 139 (2009).